First Time Loading...

EyePoint Pharmaceuticals Inc
NASDAQ:EYPT

Watchlist Manager
EyePoint Pharmaceuticals Inc Logo
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Watchlist
Price: 9.08 USD -0.22% Market Closed
Updated: Jun 11, 2024
EYPT
/
Balance Sheet
/
Cash Equivalents

EyePoint Pharmaceuticals Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

EyePoint Pharmaceuticals Inc
Cash Equivalents Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Cash Equivalents
$271m
CAGR 3-Years
25%
CAGR 5-Years
44%
CAGR 10-Years
31%
Johnson & Johnson
NYSE:JNJ
Cash Equivalents
$3.8B
CAGR 3-Years
22%
CAGR 5-Years
-2%
CAGR 10-Years
-15%
Bristol-Myers Squibb Co
NYSE:BMY
Cash Equivalents
$9.3B
CAGR 3-Years
-5%
CAGR 5-Years
5%
CAGR 10-Years
6%
Pfizer Inc
NYSE:PFE
Cash Equivalents
$719m
CAGR 3-Years
-26%
CAGR 5-Years
-18%
CAGR 10-Years
-13%
Merck & Co Inc
NYSE:MRK
Cash Equivalents
$5.6B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-10%
Eli Lilly and Co
NYSE:LLY
Cash Equivalents
$2.5B
CAGR 3-Years
-6%
CAGR 5-Years
4%
CAGR 10-Years
-4%

See Also

What is EyePoint Pharmaceuticals Inc's Cash Equivalents?
Cash Equivalents
271m USD

Based on the financial report for Mar 31, 2024, EyePoint Pharmaceuticals Inc's Cash Equivalents amounts to 271m USD.

What is EyePoint Pharmaceuticals Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
31%

Over the last year, the Cash Equivalents growth was 156%. The average annual Cash Equivalents growth rates for EyePoint Pharmaceuticals Inc have been 25% over the past three years , 44% over the past five years , and 31% over the past ten years .

ALPHA SPREAD
Join more than 146,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.